ATNM - Actinium Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 537.32M
Enterprise Value 328.97M
Trailing P/E N/A
Forward P/E 1-2.56
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.12
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.26

Trading Information

Stock Price History

Beta (3Y Monthly) 2.23
52-Week Change 3-69.70%
S&P500 52-Week Change 36.69%
52 Week High 30.8650
52 Week Low 30.2300
50-Day Moving Average 30.2597
200-Day Moving Average 30.4162

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 3573.2k
Shares Outstanding 5162.03M
Float 147.46M
% Held by Insiders 11.30%
% Held by Institutions 112.47%
Shares Short (Jun 28, 2019) 44.06M
Short Ratio (Jun 28, 2019) 42.77
Short % of Float (Jun 28, 2019) 43.47%
Short % of Shares Outstanding (Jun 28, 2019) 42.51%
Shares Short (prior month May 31, 2019) 42.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-71.74%
Return on Equity (ttm)-169.81%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.03M
Net Income Avi to Common (ttm)-23M
Diluted EPS (ttm)-0.2030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.92M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)29.47
Current Ratio (mrq)1.75
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-20.6M
Levered Free Cash Flow (ttm)-13.44M